Jerry L McLaughlin

Title: Jerry L McLaughlin: Innovator in Acetogenin Research

Introduction

Jerry L McLaughlin is a prominent inventor based in West Lafayette, IN (US). He has made significant contributions to the field of acetogenin research, holding a total of 7 patents. His work focuses on the cytotoxic properties of acetogenins, which have potential applications in cancer treatment.

Latest Patents

Among his latest patents, McLaughlin has developed selectively cytotoxic acetogenin compounds. This patent describes the isolation of three new mono-tetrahydrofuran ring acetogenins from the bark of a specific plant. Each of these compounds features a carbonyl group at the C-9 position and two hydroxyls that flank the tetrahydrofuran ring. These compounds exhibit selective cytotoxic activity against certain specific human tumor cells. Another notable patent involves bioactive acetogenins, which are novel acetogenins isolated from Annona squamosa of the family Annonaceae. These substantially pure acetogenins demonstrate cytotoxicity to human tumor cell lines, as well as selective cytotoxicity for various human tumor cell lines.

Career Highlights

Throughout his career, McLaughlin has worked with reputable organizations, including the Purdue Research Foundation and the United States of America as represented by the Secretary of Health and Human Services. His research has significantly advanced the understanding of acetogenins and their potential therapeutic applications.

Collaborations

McLaughlin has collaborated with notable colleagues such as Kenneth L Mikolajczak and James K Rupprecht. Their combined expertise has contributed to the successful development of innovative acetogenin compounds.

Conclusion

Jerry L McLaughlin's work in the field of acetogenin research has led to important advancements in cancer treatment. His patents reflect a commitment to innovation and the potential for significant medical breakthroughs.